Discrete Choice Experiment

Discrete Choice Experiments

Know the drivers of choice

What it evaluates and its advantages

The DCE methodology makes it possible to evaluate from a quantitative and statistical point of view the preferences of patients, clinicians and/or payors with respect to different therapeutic options or possible scenarios in the management of treatment and patient follow-up, or even of treatment pathways in charge in healthcare facilities or definition of PDTA.

Objective

The goal of the DCE, methodology which is based on

Survey

At the beginning of the study, the attributes and levels are identified on the basis of what is reported in the literature (scientific articles, guidelines, recommendations, etc.) or clinical experience.

Read more


AT THE ORIGIN OF ADHERENCE.

Discrete Choice Experiment to probe the preferences of patients, clinicians and payors

Possible areas of application of the DCE

Therapy

Improving Precision Medicine (patient segmentation)

PDTA / Patient Journey

Creation of registration dossiers

Acquisition of Market Insight

Endpoint definition of clinical trials on

based on parameters also chosen by the patients

Setting up research and development activities

Definition of Psychometric Scales

Comparisons between different stakeholders

(Patients, Clinicians, Payors, Pharmacists)

Individual DCE

DCE application timing

1

Before a Clinical Trial

2

During a Clinical Trial

3

After a Clinical Trial

In this case the DCE can be carried out in preparation of the dossier for the registration of a new drug, for example on therapies or on the most appropriate Patient Journey

Examples of DCE projects in different therapeutic areas

quotesArtboard 1 copy 2

New Microbiologica, 45, 4, 308-319, 2022, ISSN 1121-7138

quotesArtboard 1 copy 2

BMC Infectious Diseases (2022) 22:3

quotesArtboard 1 copy 2

HemaSphere (2022) 6:9 (e771)

quotesArtboard 1 copy 2

Journal of Hepatology 2021 vol. 75(2) |

S294–S803 - PO-1426 - p S654

quotesArtboard 1 copy 2

Acta Diabetologica (2019) 56:289–299

quotesArtboard 1 copy 2

EASD Berlin 2018 – Abstract # 881

Share by: